Last reviewed · How we verify
A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Mucinex D as Adjunct Therapy to Antibiotic Treatment of Acute Respiratory Infection
The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respiratory infection.
Details
| Lead sponsor | Adams Respiratory Therapeutics |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 600 |
| Start date | 2007-02 |
| Completion | 2007-07 |
Conditions
- Acute Respiratory Infection
- Bronchitis
- Rhinosinusitis
Interventions
- Mucinex D (600 mg guaifenesin and 60 mg pseudoephedrine HCl extended-release bi-layer tablets)
Primary outcomes
- The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respiratory infection. — 7 days
Countries
United States